Sponsor:
Massachusetts General Hospital
Code:
NCT05931497
Conditions
Long COVID
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
whole body hyperthermia
Brief summary:
Conditions
Long COVID
Study ID
NCT05931497
Start date
Aug 1, 2026
Status verified date
Nov, 2025
Completion date
Dec 1, 2026
Anticipated
Primary completion date
Sep 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
21 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: verum whole body hyperthermia
sham comparator: sham whole body hyperthermia
Interventions
whole body hyperthermia
Primary outcome measure
Central contacts
David Mischoulon, MD, PhD
dmischoulon@mgh.harvard.eduLocations
Depression Clinical and Research Program
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
David Mischoulon, MD, PhD
dmischoulon@partners.orgPrincipal Investigator:
Maren Nyer, PhD
Sponsor
Massachusetts General Hospital
Last update posted
Nov 13, 2025
Last verified
Nov, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-11-13.